Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma?. Analysis of two Gynecologic Oncology Group (GOG) trials

Gynecologic Oncology

Volumn 105, Issue 2, 2007, Pages 427-433

  Monk, Bradley J ^a   Tian, Chunqiao ^b   Rose, Peter G ^c   Lanciano, Rachelle ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c Department of OB   (United States)

^d Delaware County Memorial Hospital   (United States)

Author keywords

Cervical cancer; Chemotherapy; Clinicopathologic; Prognosis; Radiation

Indexed keywords

CISPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; ANTINEOPLASTIC AGENTS; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 34247189183     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.12.027     Document Type: Article

References (25)

1. Kosary C.L. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin. Surg. Oncol. 10 (1994) 31-46
2. Lanciano R.M., Won M., Coia L.R., and Hanks G.E. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. Int. J. Radiat. Oncol. Biol. Phys. 20 (1991) 667-676
3. Eifel P.J., Moughan J., Owen J., et al. Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study. Int. J. Radiat. Oncol. Biol. Phys. 43 (1999) 351-358
4. Eifel P.J., Moughan J., Erickson B., et al. Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: a pattern of care study. Int. J. Radiat. Oncol. Biol. Phys. 60 (2004) 1144-1153
5. National Institutes of Health Consensus Conference on Cervical Cancer. J. Natl. Cancer Inst. Monographs 21 (1996) 1-148 [Bethesda, MD, April 1-3, 1996]
6. Rose P.G. Chemoradiotherapy: the new standard care for invasive cervical cancer. Drugs 60 (2000) 1239-1244
7. The National Cancer Institute Clinical Announcement on Cervical Cancer, February 22, 1999. http://www.nci.nih.gov/clinicaltrials/digestpage/cervical-cancer-announc ement.
8. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N. Engl. J. Med. 340 (1999) 1144-1153
9. Lanciano R., Calkins A., Bundy B., et al. A randomized comparison of radiation plus weekly cisplatin versus protracted venous infusion 5-FU in combination with concurrent radiation in advanced cervix cancer: a GOG study. J. Clin. Oncol. 23 33 (2005 (Nov. 20)) 8289-8295
10. Koh W.J. Controversies in the radiotherapeutic management of cervical cancer. J. Clin. Oncol. 21 Suppl. 10 (2003) 218-223
11. Stehman F.B., Bundy B.N., Di Saia P.J., et al. Carcinoma of the cervix treated with radiation therapy. A multivariate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 67 (1991) 2776-2785
12. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, Cervical Cancer-v.1.2006. http://www.nccn.com/professionals/physician_gls/PDF/cervical.pdf.
13. Scheidler J., Hricak H., Yu K.K., Subak L., and Segal M.R. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA 278 13 (1997 (Oct. 1)) 1096-1101
14. In: DiSaia P.J., and Creasman W.T. (Eds). Invasive Cervical Cancer. 6 ed. Clinical Gynecologic Oncology (2002) 35-112
15. Havrilesky L.J., Kulasingam S.L., Matachar D.B., and Myers E.R. FDG-PET for management of cervical and ovarian cancer. Gynecol. Oncol. 97 1 (2005) 183-191
16. Singh N., and Arif S. Histopathologic parameters of prognosis in cervical cancer-a review. Int. J. Gynecol. Cancer 14 5 (2004) 741-750
17. Monk B.J., Im S., Wang J., et al. Rethinking the use of chemotherapy and radiotherapy after radical hysterectomy: a clinico-pathologic analysis of SWOG 8797/GOG 109 by the Gynecologic Oncology Group. Gynecol. Oncol. 96 3 (2005) 721-728
18. Shavers V.L., and Brown M.L. Racial and ethnic disparities in the receipt of cancer treatment. J. Natl. Cancer Inst. 94 5 (2002) 334-357
19. Farley J.H., Hines J.F., Taylor R.R., et al. Equal care ensures equal survival for African-American women with cervical carcinoma. Cancer 91 4 (2001) 869-873
20. Greer B.E., Koh W.J., Stelzer K.J., et al. Expanded pelvic radiotherapy fields for treatment of local-regionally advanced carcinoma of the cervix: outcome and complications. Am. J. Obstet. Gynecol. 174 4 (1996) 1141-1149
21. Eifel P.J., and Thames H.D. Has the influence of treatment duration on local control of carcinoma of the cervix been defined?. Int. J. Radiat. Oncol. Biol. Phys. 32 5 (1995) 1527-1529
22. Petereit D.G., Sarkaria J.N., Chappell R., et al. The adverse effect of treatment prolongation in cervical carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 32 5 (1995) 1301-1307
23. Fyles A.W., Pintilie M., Kirkbride P., Levin W., Manchul L.A., and Rawlings G.A. Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis. Radiother. Oncol. 35 (1995) 107-117
24. Lanciano R. Optimizing radiation parameters for cervical cancer. Semin. Radiat. Oncol. 10 (2000) 36-43
25. Machtay M., Hsu C., Komaki R., Sause W.T., Swann R.S., Langer C.J., et al. Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience. Int. J. Radiat. Oncol. Biol. Phys. 3 3 (2005 (Nov 1)) 667-671